{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:19:43Z","timestamp":1751429983081,"version":"3.41.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jbspin.2025.105877","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T17:15:30Z","timestamp":1740503730000},"page":"105877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and ultrasonographic predictors of disease activity after TNF-\u03b1 inhibitor spacing in patients with psoriatic arthritis"],"prefix":"10.1016","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0714-5902","authenticated-orcid":false,"given":"Antonio","family":"Marchesoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierluigi","family":"Macchioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Ciancio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilda","family":"Sandri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alen","family":"Zabotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Montaguti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gentiana","family":"Vukatana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Mascella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donatella","family":"Chessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Verduci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Govoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia","family":"Spinella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Zuliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Bruschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazzarena","family":"Malavolta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariacristina","family":"Focherini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Salvarani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2025.105877_bib0100","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41584-022-00798-0","article-title":"Group for research and assessment of psoriasis and psoriatic arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021","volume":"18","author":"Coates","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105877_bib0105","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/ard-2024-225531","article-title":"EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update","volume":"83","author":"Gossec","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2025.105877_bib0110","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s40265-018-0994-3","article-title":"Tapering and discontinuation of biologics in patients with psoriatic arthritis with low disease activity","volume":"78","author":"Ye","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.jbspin.2025.105877_bib0115","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1093\/rheumatology\/kew464","article-title":"Dosing down with biologic therapies: a systematic review and clinicians\u2019 perspective","volume":"56","author":"Edwards","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2025.105877_bib0120","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3899\/jrheum.161567","article-title":"Rebound in measures of disease activity and symptoms in Corrona registry patients with psoriatic arthritis who discontinue tumor necrosis factor inhibitor therapy after achieving low disease activity","volume":"45","author":"Harrold","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105877_bib0125","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1093\/rheumatology\/keab741","article-title":"Tumour necrosis factor inhibitor dose adaptation in psoriatic arthritis and axial spondyloarthritis (TAPAS): a retrospective cohort study","volume":"61","author":"Michielsens","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2025.105877_bib0130","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1136\/annrheumdis-2022-222260","article-title":"Treat-to-target dose reduction and withdrawal strategy of TNF inhibitors in psoriatic arthritis and axial spondyloarthritis: a randomised controlled non-inferiority trial","volume":"81","author":"Michielsens","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2025.105877_bib0135","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1007\/s10067-021-05728-1","article-title":"High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry","volume":"40","author":"Fornaro","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105877_bib0140","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1111\/bcp.15806","article-title":"Predicting successful biologics tapering in patients with inflammatory arthritis: secondary analyses based on the BIOlogical Dose OPTimisation (BIODOPT) trial","volume":"89","author":"Uhrenholt","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jbspin.2025.105877_bib0145","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/03009742.2023.2164979","article-title":"t al. Disease activity-guided tapering of biologics in patients with inflammatory arthritis: a pragmatic, randomized, open-label, equivalence trial","volume":"52","author":"Uhrenholt","year":"2023","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105877_bib0150","first-page":"1088","article-title":"Persistence of remission after lengthening of golimumab in inflammatory joint diseases","volume":"41","author":"Damiani","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105877_bib0155","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/03009742.2022.2028364","article-title":"Interval prolongation of etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a randomized controlled trial","volume":"52","author":"Ruwaard","year":"2023","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105877_bib0160","doi-asserted-by":"crossref","first-page":"112167","DOI":"10.1016\/j.intimp.2024.112167","article-title":"Risk of disease flare in spondyloarthritis patients after tapering tumor necrosis factor inhibitors: a meta-analysis and literature review","volume":"134","author":"Min","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jbspin.2025.105877_bib0165","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2025.105877_bib0170","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/ard.2008.102053","article-title":"Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment","volume":"69","author":"Coates","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2025.105877_bib0175","doi-asserted-by":"crossref","first-page":"e000596","DOI":"10.1136\/rmdopen-2017-000596","article-title":"Long-term persistence of TNF-inhibitor treatment in patients with psoriatic arthritis. Data from the British Society for Rheumatology Biologics Register","volume":"4","author":"Fagerli","year":"2018","journal-title":"RMD Open"},{"key":"10.1016\/j.jbspin.2025.105877_bib0180","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1093\/rheumatology\/kew326","article-title":"The influence of obesity on response to tumour necrosis factor-alpha inhibitors in psoriatic arthritis: results from the DANBIO and ICEBIO registries","volume":"55","author":"Hojgaard","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2025.105877_bib0185","doi-asserted-by":"crossref","first-page":"1096547","DOI":"10.3389\/fmed.2022.1096547","article-title":"Residual inflammation in psoriatic arthritis patients in stable minimal disease activity","volume":"9","author":"Macchioni","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jbspin.2025.105877_bib0190","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3899\/jrheum.161347","article-title":"Utility of Power Doppler Ultrasound\u00a0\u2013\u00a0detected synovitis for the prediction of short-term flare in 31 psoriatic patients with arthritis in clinical remission","volume":"44","author":"Ruta","year":"2017","journal-title":"J Rheumatol"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X25000363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X25000363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T18:40:10Z","timestamp":1751395210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X25000363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1297319X25000363"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2025.105877","relation":{},"ISSN":["1297-319X"],"issn-type":[{"type":"print","value":"1297-319X"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and ultrasonographic predictors of disease activity after TNF-\u03b1 inhibitor spacing in patients with psoriatic arthritis","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2025.105877","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\ufffdt\ufffd Fran\ufffdaise de Rhumatologie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105877"}}